Skip to main content

3 Result(s)

within Jacob Schlossman Remove this filter

and

  1. No Access

    Article

    Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation

    Pseudoprogression (PsP) remains an elusive and clinically important, yet ill-defined, phenomena that, generally, involves a period of early radiographic progression (enhancement) followed by a period of radiog...

    Akifumi Hagiwara, Jacob Schlossman, Soroush Shabani… in Journal of Neuro-Oncology (2022)

  2. No Access

    Article

    Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

    To examine whether the rate of change in maximum 18F-FDOPA PET uptake and the rate of change in non-enhancing tumor volume could predict malignant transformation and residual overall survival (OS) in low grade gl...

    Talia C. Oughourlian, **gwen Yao, Jacob Schlossman… in Journal of Neuro-Oncology (2020)

  3. No Access

    Article

    pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma

    The objective of the current study was to explore the efficacy of using pH-weighted amine CEST-EPI as a potential non-invasive imaging biomarker for treatment response and/or failure in recurrent GBM patients ...

    **gwen Yao, Caleb Hock Pang Tan, Jacob Schlossman… in Journal of Neuro-Oncology (2019)